A Pro-Diabetogenic mtDNA Polymorphism in the Mitochondrial-Derived Peptide, MOTS-c
Hirofumi ZempoiD, Su‐Jeong KimiD, Noriyuki FukuiD, Yuichiro NishidaiD, Yasuki HigakiiD, Junxiang WaniD, Kelvin YeniD, Brendan MilleriD, Roberto VicinanzaiD, Eri Miyamoto‐MikamiiD, Hiroshi KumagaiiD, Hisashi NaıtoiD, Jialin Xiao, Hemal H. MehtaiD, Changhan David LeeiD, Megumi HaraiD, Yesha M. PateliD, Veronica Wendy SetiawaniD, Timothy M. MooreiD, Andrea Lynn HeveneriD, Yoichi SutohiD, Atsushi ShimizuiD, Kaname KojimaiD, Kengo KinoshitaiD, Yasumichi AraiiD, , Pinchas CoheniD
Abstract
Type 2 Diabetes (T2D) is an emerging public health problem in Asia. An Asian mitochondrial DNA variation m.1382A>C (rs111033358) leads to a K14Q amino acid replacement in MOTS-c, an insulin sensitizing mitochondrial-derived peptide. Meta-analysis of three cohorts (n=27,527, J-MICC, MEC, and TMM) showed that males but not females with the C-allele exhibit a higher prevalence of T2D. Furthermore, in J-MICC, only males with the C-allele in the lowest tertile of physical activity increased their prevalence of T2D, demonstrating a kinesio-genomic interaction. High-fat fed, male mice injected with MOTS-c showed reduced weight and improved glucose tolerance, but not K14Q-MOTS-c treated mice. Like the human data, female mice were unaffected. Mechanistically, K14Q-MOTS-c leads to diminished insulin-sensitization in vitro. Thus, the m.1382A>C polymorphism is associated with susceptibility to T2D in men, possibly interacting with exercise, and contributing to the risk of T2D in sedentary males by reducing the activity of MOTS-c.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 50
- FWCI
- 2.90
- Field percentile
- top 7%
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Decreased sarcomeric mitochondrial creatine kinase 2 impairs skeletal muscle mitochondrial function independently of insulin action in type 2 diabetes
David Rizo‐Roca, Dimitrius Santiago P.S.F. Guimarães, … Anna Krook·Science Translational MedicinePeer-reviewed·Oct 9, 2024
- The ortholog of the Human T2D Risk Gene STEAP2 is Required for Glucose Stimulated Insulin Secretion in Mice
Avery Hawthorne, Kai Kelly, … Klaus H. Kaestner·bioRxiv·Oct 2, 2026
- Perturbed Mitochondrial Metabolism in Islets from Donors with Type-2 Diabetes
Jiangming Sun, Ruchi Jain, … Hindrik Mulder·bioRxiv·Nov 1, 2017
- Nuclear regulatory disturbances precede and predict the development of Type-2 diabetes in Asian populations
Pritesh Jain, Hong Kiat Ng, … John Campbell Chambers·medRxiv·Feb 14, 2025
- AKT2 deficiency causes sarcopenia and metabolic disorder of skeletal muscle
- Functional dissection of metabolic trait-associated gene regulation in steady state and stimulated human skeletal muscle cells
Kirsten Nishino, Gabriella Bloss, … Adelaide Tovar·bioRxiv·Nov 28, 2024